The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Celldex
Consulting or Advisory Role - Celldex
Research Funding - Agensys (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
A phase 1 dose-escalation trial of intratumoral TTI-621, a novel immune checkpoint inhibitor targeting CD47, in subjects with relapsed or refractory percutaneously-accessible solid tumors and mycosis fungoides.
 
John A. Thompson
No Relationships to Disclose
 
Oleg Akilov
Consulting or Advisory Role - Actelion; Celgene; Mallinckrodt
Research Funding - Actelion (Inst); Trillium Therapeutics (Inst)
Travel, Accommodations, Expenses - Soligenix
 
Christiane Querfeld
Consulting or Advisory Role - Actelion; Celgene; MiRagen
 
Matthew H. Taylor
Honoraria - Blueprint Medicines; Bristol-Myers Squibb; Eisai; Trillium Therapeutics
Consulting or Advisory Role - Blueprint Medicines; Bristol-Myers Squibb; Eisai; Trillium Therapeutics
Speakers' Bureau - Eisai
 
Lisa Johnson
Employment - Emergent BioSolutions; Trillium Therapeutics
 
Tina Catalano
Employment - Apotex; Trillium Therapeutics
 
Penka S. Petrova
Employment - Trillium Therapeutics
Leadership - Trillium Therapeutics
 
Robert A. Uger
Employment - Trillium Therapeutics
Leadership - Trillium Therapeutics
Patents, Royalties, Other Intellectual Property - Trillium Therapeutics
 
Meghan Irwin
Employment - Roche; Trillium Therapeutics
Stock and Other Ownership Interests - Roche; Trillium Therapeutics
 
Eric L. Sievers
Employment - Seagen; Trillium Therapeutics
Leadership - Trillium Therapeutics
Stock and Other Ownership Interests - Seagen; Trillium Therapeutics
Consulting or Advisory Role - MEI Pharma